{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for aminosalicylic root_references_citation in Reference Text / Citation (approximate match)
Status:
Possibly Marketed Outside US
Source:
HUCORD HSCM-100 Ampoule by Hucord Co., Ltd.
(2015)
Source URL:
First approved in 2015
Source:
HUCORD HSCM-100 Ampoule by Hucord Co., Ltd.
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT01347996: Phase 4 Interventional Completed Acute Myeloid Leukemia
(2009)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT04013581: Phase 4 Interventional Completed Type 2 Diabetes Mellitus
(2019)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT02964403: Phase 4 Interventional Unknown status Pancreatitis, Acute
(2016)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT04619927: Phase 4 Interventional Recruiting Peripheral Arterial Disease
(2021)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT02710747: Phase 4 Interventional Unknown status Heart Valve Disease
(2015)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT04244383: Phase 4 Interventional Unknown status Hepatitis C
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02476019: Phase 2 Interventional Completed Obesity
(2015)
Source URL:
Class:
NUCLEIC ACID
